group exposed
OtherAssessment by Brunet Lezine scale
NCT Number: NCT02223936
Prospective, multicenter study following for 2 years, 250 children who presented during the first trimester of pregnancy an isolated nuchal translucency over the 95th percentile of Nicolaïdes Curves on ultrasound and comparing them to a control group of 250 children whose pregnancy was normal. Evaluating morbidity, mortality, growth and the neurodevelopment of each group by a Brunet Lezine scale. Evaluating anxiety and depression in parents of those children using a scale.
Looking for future studies?
Notify MeUp to 26 month
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-
Confirmation of the enlargement of nuchal tranlucency by a sonographer referent OR ultrasound abnormality neck restraint by sonographers referents replay after the initial shots (the notion of transience of the pathology of the neck being allowed) with in all cases:
Exclusion criteria
Inclusion criteria
for control group
Assessment by Brunet Lezine scale
Not exposed group
Time frame: Assessment at the age of 2 years + / - 45 days for each patient
assessed by the Brunet Lezine test
Time frame: at the age of 2 years + / - 45 days
assessed by the Brunet Lezine test
Time frame: at 3 months, 1 year and 2 years
assessed by measurement
Time frame: any time after birth and before 2 years + / - 45 days
nterview
Time frame: at the consultation at the age of 2 years + / - 45 days of the children
assessment of the questionnaire of posttraumatic stress and HAD scale by the parents during the consultation of the two-year child
Hospices Civils de Lyon
Other
Acronym: EDEN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03113903
Anxiety Disorders, Behavior
Clermont-Ferrand, France
View Trial DetailsNCT04257227
Anxiety Disorders, Behavior
Ottawa, Ontario, Canada
View Trial DetailsNCT07741422
Anxiety, Anxiety Disorders
Guangzhou, Guangdong, China
View Trial DetailsNCT06942637
Adolescents, Anxiety
Bandung, West Java, Indonesia
View Trial Details